The BWX Limited (ASX: BWX) share price has fallen 19% in early trading after giving the ASX a trading update.
BWX said that its normalised earnings before interest, tax, depreciation and amortisation (EBITDA) in FY19 is expected to be broadly in line with FY18’s normalised EBITDA of $40.3 million.
The new BWX CEO Myles Anceschi put the blame firmly on the failed takeover “There has been significant disruption and loss of business momentum at the beginning of FY19 due to the now failed management buyout (MBO) process. The MBO diverted significant management time and resources, and several key projects were delayed resulting in an impact on the business.”
BWX outlined a number of things that went wrong. First, there was an extended delay in a return to normal operations of its ERP program. This apparently contributed to lost domestic sales and materially higher operational costs for Sukin and Nourished Life.
The multi-brand selling platform roll-out was significantly delayed, resulting in lost sales. A relocation of the Nourished Life Warehouse and the consolidation of four US warehouses to one also temporarily impacted sales and costs.
BWX said all of the above, and other, initiatives are important for future growth, for generating cost efficiencies and operating leverage.
Despite all of the above problems, CEO Anceschi said that its categories are growing in all active markets.
Is it now a buy?
It has been a fairly disastrous period for BWX’s reputation and share price since initiating the acquisitions in the US.
Only time will tell whether it’s a been a bit of bad luck or whether BWX is making excuses for poor performance.
If BWX can achieve the same EBITDA and net profit after tax (NPAT) in FY19 as FY18, with growth likely in FY20 and beyond, then today’s price could end up being cheap in the long run.
I still believe it operates in an attractive industry and a globally-growing revenue base is useful for BWX compared to domestically-focused shares.
Before this update, I was thinking I wouldn’t buy any more shares until after the half-year result. If it achieves the same statutory earnings per share (EPS) of 16.6 cents as FY18, which includes acquisition costs, then it’s trading at 16x FY19’s earnings.
There is blood on BWX’s streets, but I don’t plan on buying until at least seeing the half-year result and some reassurance that the business’ segments, particularly Sukin, are still growing revenue and there will further profit margin growth in the future.
For my portfolio, I’d much rather buy this top share which has been a reliable profit grower rather than BWX at the moment.
You might not know this market leader's name, but it's rapidly expanding into a highly profitable niche market here in Australia. Even better, the shares boast a strong, fully franked dividend that should balloon in the years to come. In other words, we're looking at the holy grail of incredible long-term growth potential AND income you can watch accruing in your account in real time!
Simply click here to grab your FREE copy of this up-to-the-minute research report on our #1 dividend share recommendation now.
Motley Fool contributor Tristan Harrison owns shares of BWX Limited. The Motley Fool Australia owns shares of and has recommended BWX Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.